Camp4 Therapeutics Corporation
CAMP
$3.25
-$0.06-1.81%
NASDAQ
| 09/30/2025 | 06/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -46.89% | 74.48% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -46.89% | 74.48% | |||
| Cost of Revenue | -9.54% | 1.94% | |||
| Gross Profit | 3.22% | 4.76% | |||
| SG&A Expenses | 9.90% | 9.71% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -3.94% | 4.06% | |||
| Operating Income | -0.99% | 0.55% | |||
| Income Before Tax | -19.96% | -1.24% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -19.96% | -1.24% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -19.96% | -1.24% | |||
| EBIT | -0.99% | 0.55% | |||
| EBITDA | -1.14% | 0.64% | |||
| EPS Basic | 11.34% | -1.22% | |||
| Normalized Basic EPS | 14.22% | -1.19% | |||
| EPS Diluted | 11.34% | -1.22% | |||
| Normalized Diluted EPS | 14.22% | -1.19% | |||
| Average Basic Shares Outstanding | 35.29% | 0.03% | |||
| Average Diluted Shares Outstanding | 35.29% | 0.03% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||